Endura Therapeutics

Private

South San Francisco, CaliforniaHealthcare & Life Scienceshttps://enduratx.com/

Last Round

Grant

May 15, 2025

Company Overview

Endura Therapeutics is a biotechnology company developing a platform for small molecule drug discovery that targets RNA to create treatments for diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

RNA-targeting small moleculessmall molecule drug discoverydrug discovery platformundruggable targetsAI drug discoverycovalent drug discoverymRNA targetingAI-native biotechnext-generation sequencingNGSchemo-genomicspreclinical biotechnologySmall Business Innovation ResearchSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endura Therapeutics Comparables

Compare Endura Therapeutics with similar companies based on industry and business-model similarity.

Endura Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
ReviR Therapeutics	86%
Wayfinder Biosciences	85%
Atomic AI	84%

View all Comparables

Endura Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 15, 2025
Seed	Sep 6, 2024

View all Funding Rounds

Endura Therapeutics Investors

Notable investors and investment history

Endura Therapeutics investors
Investor	Rounds
Scribble Ventures	Seed
Calm Ventures	Seed
SciFounders	Seed
National Science Foundation	Seed, Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 15, 2025
$303K grant received from the National Science Foundation.
Sep 6, 2024
Raised capital from Calm Ventures, SciFounders, Scribble Ventures, and NSF.

View all signals

Endura Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Endura Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Endura Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California

Year Founded2024

Last FundingMay 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.